178 filings
Page 2 of 9
8-K
cxpydc m1an2fp98
30 Sep 22
Regulation FD Disclosure
7:58am
8-K
nr0w l2qnfrnc4stmgp7
21 Sep 22
Intercept Pharmaceuticals Announces Summary of Key Actions in Strategic Financial Repositioning
7:30am
8-K
89ug139
20 Sep 22
Other Events
4:01pm
8-K
ivc00b72
12 Sep 22
Entry into a Material Definitive Agreement
7:30am
8-K
09tgxubu
8 Sep 22
Unregistered Sales of Equity Securities
5:00pm
8-K
c51w3
7 Sep 22
Entry into a Material Definitive Agreement
7:30am
8-K
dx0e5g1
6 Sep 22
Unregistered Sales of Equity Securities
5:15pm
8-K
91k9f0povp
2 Sep 22
Entry into a Material Definitive Agreement
7:31am
8-K
2cednw1zougze4ak55
26 Aug 22
Unregistered Sales of Equity Securities
4:01pm
8-K
dw8 l15df4c1dlm
19 Aug 22
Intercept Pharmaceuticals Announces Repurchase of Convertible Notes
7:30am
8-K
qxma39
16 Aug 22
Other Events
4:01pm
8-K
57hpgh 2hjq292
3 Aug 22
Intercept Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
7:00am
8-K
oknqzbzpt
26 Jul 22
Other Events
7:30am
8-K
gymt5
8 Jul 22
Entry into a Material Definitive Agreement
5:29pm
8-K
z9jradgsssgyr
7 Jul 22
Regulation FD Disclosure
7:30am
8-K
y4q 93uytp3an
1 Jul 22
Regulation FD Disclosure
4:45pm
8-K
3kspz11el3y0q93ahi
21 Jun 22
Other Events
4:02pm
8-K
2xkcql
6 Jun 22
Intercept Provides Update on NASH Regulatory Timeline
6:30am
8-K
biiadlh0nk gm7xjdk
3 Jun 22
Intercept Announces New Clinical Trial and Real-World Outcomes Data
7:45am
8-K
2o6o6zff
2 Jun 22
Departure of Directors or Certain Officers
4:06pm